NASDAQ:MBIO
Mustang Bio
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.mustangbio.comipo date
Aug 22, 2017
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic ...Show More
Earnings
Earnings Release in 17 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus